Quantitative analysis of CD34+ cells confirmed that AMD3100 blocked infiltration of ASCs, with significantly lower levels of CD34+ cells in the + AMD group than in the PBS group over the first 7 days (Fig. 6B, C). This evidence concerns the gene CD34 and age-related macular degeneration.